Capitalizing On Hair Loss Market In The UK

Although the UK hair loss treatment market has never been so profitable,many pharmacists may be missing out on this profit, according to the latest figures from Pharmacia & Upjohn, the maker of the male pattern baldness therapy Regaine/Rogaine (minoxidil). These reveal a 21% rise in consumer purchasing growth from 1996 to 1997.

However, the figures, based on A C Nielsen data, also show that only one-third of independent pharmacies actually maintains a "visible" stock of Regaine. This means that many potential customers are walking out of pharmacies empty-handed because they may be too embarrassed to ask for a product which they cannot see.

With media attention focused around the world on new treatments and genetic discoveries, men and women who are uncomfortable with their hereditary hair loss are being bombarded with ideas that could help them. So, says P& U, it makes sense to display the only (non-prescription) medically-proven treatment for this type of hair loss.